Skip to main content
. 2017 Apr 6;11:182. doi: 10.3389/fnins.2017.00182

Table 1.

Effect of injected compounds on resting MAP, HR, SSNA, and RSNA.

Injected compound n MAP, mmHg HR, beats/min SSNA, μV RSNA, μV
Pre Post Pre Post Pre Post Pre Post
NS-TG 6 107 ± 6 117 ± 6* 350 ± 7 359 ± 6 0.03 ± 0.005 0.05 ± 0.008* 0.03 ± 0.009 0.05 ± 0.013*
0.75 nmol, PVN
HS-TG 6 106 ± 4 114 ± 5* 325 ± 14 330 ± 15 0.04 ± 0.009 0.05 ± 0.010* 0.03 ± 0.006 0.03 ± 0.007*
0.75 nmol, PVN
DMSO, PVN 3 111 ± 7 112 ± 6 352 ± 35 348 ± 34 0.03 ± 0.001 0.03 ± 0.005 0.02 ± 0.003 0.02 ± 0.004
Anatomy control (TG outside PVN) 5 111 ± 6 112 ± 6 337 ± 19 334 ± 22 0.02 ± 0.002 0.02 ± 0.002 0.04 ± 0.008 0.02 ± 0.007
TG intravenous 4 111 ± 8 107 ± 10 343 ± 23 344 ± 21 0.03 ± 0.003 0.02 ± 0.003 0.04 ± 0.009 0.02 ± 0.01

Values are mean ± SE; n, number of rats; SSNA, splanchnic sympathetic nerve activity; RSNA, renal sympathetic nerve activity; MAP, mean arterial pressure; HR, heart rate; TG, thapsigargin; PVN, paraventricular nucleus.

*

P < 0.05 vs. pre-treatment.